Biotech Stock Roundup: Geron Gains On Interim Data, OncoMed Slumps On Pipeline Setback
April 12, 2017 at 11:13 AM EDT
Several companies including Geron and OncoMed provided key pipeline updates this week. While Geron’s shares were up this week, OncoMed’s shares plunged and hit a 52-week low.
